Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Naber

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
Annals of the New York Academy of Sciences|January 1, 1982
Endorphins in the cerebrospinal fluid of psychiatric patientsD Pickar, D Naber, R M Post, et al.
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Principles of practice from the European expert panel on the contemporary treatment of schizophreniaA C Altamura, J Bobes, D C Owens, et al.
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
HIV-related ocular microangiopathic syndrome and cognitive functioningS A Geier, C Perro, V Klauss, et al.
Fortschritte Der Neurologie-Psychiatrie|January 1, 1986
[Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables]M Albus, D Naber, M Ackenheil, et al.
Pharmacopsychiatry|September 29, 2005
Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record studyM Lambert, P Conus, B G Schimmelmann, et al.
Substance and Alcohol Actions/Misuse|January 1, 1980
Assay of endogenous opiate receptor ligands in human CSF and plasmaD Naber, D Pickar, R A Dionne, et al.
Pharmacopsychiatry|January 8, 2013
Predicting a 'combined treatment outcome' in chronic schizophrenia: the role of demographics, symptomatology, functioning and subjective well-beingD Naber, S Kollack-Walker, J Chen, et al.
The American Journal of Psychiatry|November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteersD Naber, D Pickar, R M Post, et al.
Psychological Medicine|November 22, 2011
Unmet needs in patients with first-episode schizophrenia: a longitudinal perspectiveK Landolt, W Rössler, T Burns, et al.
Biological Psychiatry|February 15, 1989
Repeated naloxone administration in schizophrenia: a phase II World Health Organization StudyD Pickar, W E Bunney, P Douillet, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Annals of the New York Academy of Sciences|January 1, 1982
Endorphins in the cerebrospinal fluid of psychiatric patientsD Pickar, D Naber, R M Post, et al.
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Principles of practice from the European expert panel on the contemporary treatment of schizophreniaA C Altamura, J Bobes, D C Owens, et al.
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
HIV-related ocular microangiopathic syndrome and cognitive functioningS A Geier, C Perro, V Klauss, et al.
Fortschritte Der Neurologie-Psychiatrie|January 1, 1986
[Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables]M Albus, D Naber, M Ackenheil, et al.
Pharmacopsychiatry|September 29, 2005
Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record studyM Lambert, P Conus, B G Schimmelmann, et al.
Substance and Alcohol Actions/Misuse|January 1, 1980
Assay of endogenous opiate receptor ligands in human CSF and plasmaD Naber, D Pickar, R A Dionne, et al.
Pharmacopsychiatry|January 8, 2013
Predicting a 'combined treatment outcome' in chronic schizophrenia: the role of demographics, symptomatology, functioning and subjective well-beingD Naber, S Kollack-Walker, J Chen, et al.
The American Journal of Psychiatry|November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteersD Naber, D Pickar, R M Post, et al.
Psychological Medicine|November 22, 2011
Unmet needs in patients with first-episode schizophrenia: a longitudinal perspectiveK Landolt, W Rössler, T Burns, et al.
Biological Psychiatry|February 15, 1989
Repeated naloxone administration in schizophrenia: a phase II World Health Organization StudyD Pickar, W E Bunney, P Douillet, et al.
Pageof 20